Cargando…
Transcranial magnetic stimulation as biomarker of excitability in drug development: A randomized, double‐blind, placebo‐controlled, cross‐over study
AIMS: The purpose of this study was to investigate pharmacodynamic effects of drugs targeting cortical excitability using transcranial magnetic stimulation (TMS) combined with electromyography (EMG) and electroencephalography (EEG) in healthy subjects, to further develop TMS outcomes as biomarkers f...
Autores principales: | Ruijs, Titia Q., Heuberger, Jules A. A. C., de Goede, Annika A., Ziagkos, Dimitrios, Otto, Marije E., Doll, Robert J., van Putten, Michel J. A. M., Groeneveld, Geert Jan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9303426/ https://www.ncbi.nlm.nih.gov/pubmed/35028950 http://dx.doi.org/10.1111/bcp.15232 |
Ejemplares similares
-
Effects of Mexiletine and Lacosamide on Nerve Excitability in Healthy Subjects: A Randomized, Double‐Blind, Placebo‐Controlled, Crossover Study
por: Ruijs, Titia Q., et al.
Publicado: (2022) -
Muscle velocity recovery cycles as pharmacodynamic biomarker: Effects of mexiletine in a randomized double‐blind placebo‐controlled cross‐over study
por: Ruijs, Titia Q., et al.
Publicado: (2022) -
Transcranial magnetic stimulation as a translational biomarker for AMPA receptor modulation
por: O’Donnell, Patricio, et al.
Publicado: (2021) -
Machine Learning Techniques for Developing Remotely Monitored Central Nervous System Biomarkers Using Wearable Sensors: A Narrative Literature Review
por: ZhuParris, Ahnjili, et al.
Publicado: (2023) -
Targeting for Success: Demonstrating Proof-of-Concept with Mechanistic Early Phase Clinical Pharmacology Studies for Disease-Modification in Neurodegenerative Disorders
por: Vissers, Maurits F. J. M., et al.
Publicado: (2021)